Cover Image

HARDBACK
$52.95



View/Hide Left Panel

value of the cost per QALY gained is $5,000. If the target population was all 12-year-olds, the annualized present value of the cost per QALY gained is $3,000. Using committee assumptions of less-than-ideal utilization and including time and monetary costs until a vaccine program is implemented, the annualized present value of the cost per QALY gained is $7,400. If the target population was all 12-year-olds (assuming 50% utilization), the annualized present value of the cost per QALY gained is $4,000.

See Chapters 4 and 5 for details on the methods and assumptions used by the committee for the results reported.

READING LIST

Bhandari BN, Wright TL. Hepatitis C: An Overview. Annual Review of Medicine 1995; 46:309–317.


Lemon SM, Brown EA. Hepatitis C Virus. In: Principles and Practice of Infectious Diseases. GL Mandell, JE Bennett, Dolin R eds. New York, NY: Churchill Livingstone, 1995, pp. 1474–1486.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement